These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 25975016)
1. Possible influence of some foods on the metabolism of ibrutinib. Kronabel D Clin Lab; 2015; 61(3-4):443-4. PubMed ID: 25975016 [TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro. Xu RA; Wen J; Tang P; Wang C; Xie S; Zhang BW; Zhou Q; Cai JP; Hu GX Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):383-387. PubMed ID: 29117640 [TBL] [Abstract][Full Text] [Related]
3. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Wang JS; DeVane CL Drug Metab Dispos; 2003 Jun; 31(6):742-7. PubMed ID: 12756206 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro. Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine. Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333 [TBL] [Abstract][Full Text] [Related]
6. P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability. van Hoppe S; Rood JJM; Buil L; Wagenaar E; Sparidans RW; Beijnen JH; Schinkel AH Mol Pharm; 2018 Nov; 15(11):5124-5134. PubMed ID: 30247919 [TBL] [Abstract][Full Text] [Related]
7. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. Pan L; Belpaire FM Eur J Clin Pharmacol; 1999 Oct; 55(8):599-604. PubMed ID: 10541779 [TBL] [Abstract][Full Text] [Related]
8. Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist. Ghosal A; Ramanathan R; Yuan Y; Hapangama N; Chowdhury SK; Kishnani NS; Alton KB Drug Metab Dispos; 2007 Dec; 35(12):2186-95. PubMed ID: 17827338 [TBL] [Abstract][Full Text] [Related]
9. CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. Zamperini C; Dreassi E; Vignaroli G; Radi M; Dragoni S; Schenone S; Musumeci F; Valoti M; Antiochia R; Botta M Drug Metab Pharmacokinet; 2014; 29(6):433-40. PubMed ID: 24850316 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human cytochrome P450s involved in the bioactivation of clozapine. Dragovic S; Gunness P; Ingelman-Sundberg M; Vermeulen NP; Commandeur JN Drug Metab Dispos; 2013 Mar; 41(3):651-8. PubMed ID: 23297297 [TBL] [Abstract][Full Text] [Related]
11. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. Walsky RL; Obach RS; Hyland R; Kang P; Zhou S; West M; Geoghegan KF; Helal CJ; Walker GS; Goosen TC; Zientek MA Drug Metab Dispos; 2012 Sep; 40(9):1686-97. PubMed ID: 22645092 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 3A4 and 2D6-mediated metabolism of leisure and medicinal teas. Tam TW; Liu R; Saleem A; Arnason JT; Krantis A; Foster BC J Pharm Pharm Sci; 2014; 17(3):294-301. PubMed ID: 25224344 [TBL] [Abstract][Full Text] [Related]
13. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes. Savai J; Varghese A; Pandita N; Chintamaneni M Phytother Res; 2015 May; 29(5):785-90. PubMed ID: 25684704 [TBL] [Abstract][Full Text] [Related]
14. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452 [TBL] [Abstract][Full Text] [Related]
15. Isolation, synthesis, and drug interaction potential of secondary metabolites derived from the leaves of miracle tree (Moringa oleifera) against CYP3A4 and CYP2D6 isozymes. Fantoukh OI; Albadry MA; Parveen A; Hawwal MF; Majrashi T; Ali Z; Khan SI; Chittiboyina AG; Khan IA Phytomedicine; 2019 Jul; 60():153010. PubMed ID: 31301970 [TBL] [Abstract][Full Text] [Related]
16. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism. Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model. Jamshidfar S; Ardakani YH; Lavasani H; Rouini M Daru; 2017 Jun; 25(1):16. PubMed ID: 28659160 [TBL] [Abstract][Full Text] [Related]
18. Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What? Gazzaz M; Kinzig M; Schaeffeler E; Jübner M; Hsin CH; Li X; Taubert M; Trueck C; Iltgen-Breburda J; Kraus D; Queckenberg C; Stoffel M; Schwab M; Sörgel F; Fuhr U Clin Pharmacol Ther; 2018 Dec; 104(6):1249-1259. PubMed ID: 29633238 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro. He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485 [TBL] [Abstract][Full Text] [Related]
20. Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans. Thörn HA; Lundahl A; Schrickx JA; Dickinson PA; Lennernäs H Eur J Pharm Sci; 2011 Jun; 43(3):89-98. PubMed ID: 21447389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]